Ken Takanashi Net Worth & Insider Trades

Ken Takanashi - Director, Satsuma Pharmaceuticals, Inc

As of June 8, 2023

What is Ken Takanashi's Net Worth?

The current estimated net worth of Satsuma Pharmaceuticals, Inc's Director, Ken Takanashi, is estimated to be about $30.7M . Ken Takanashi owns about 24,847,694 units of Satsuma Pharmaceuticals, Inc common stock. In the last 4 years at Satsuma Pharmaceuticals, Inc, Ken Takanashi has sold an estimated value of $0 worth.

What is Ken Takanashi's Past Insider Trading?

Ken Takanashi's largest purchase order was 22,053,581 units , worth over $20.07M on June 8, 2023. In total, Ken Takanashi has made about 5 transactions over 4 years of their time at Satsuma Pharmaceuticals, Inc. Ken Takanashi usually trades in June, with the busiest year in 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ken Takanashi

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Ken Takanashi's' Mailing Address?

  • Mailing address is C/o Wave Life Sciences Ltd. 733 Concord Ave. Cambridge MA 02138 MA

What are Satsuma Pharmaceuticals, Inc's Past Insider Trades?

Satsuma Pharmaceuticals, Inc's most recent insider trade came on June 8, 2023 by Ken Takanashi who bought 22,053,581 units worth $20.07M . In the last 4 years, insiders at Satsuma Pharmaceuticals, Inc have sold an estimated value of $8.38M and bought an estimated value of $111.49M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Commodore Capital Lp,  Detlef Albrecht, Chief Medical Officer,  and Thomas P. O'Neil, Chief Financial Officer .

Satsuma Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...